{"id":1927,"date":"2026-01-08T16:00:00","date_gmt":"2026-01-08T16:00:00","guid":{"rendered":"https:\/\/hscodematch.com\/news\/chile-updates-pharmaceutical-product-serial-control-framework\/"},"modified":"2026-09-14T06:29:23","modified_gmt":"2026-09-14T06:29:23","slug":"chile-updates-pharmaceutical-product-serial-control-framework","status":"publish","type":"post","link":"https:\/\/hscodematch.com\/news\/chile-updates-pharmaceutical-product-serial-control-framework\/","title":{"rendered":"Chile Updates Pharmaceutical Product Serial Control Framework"},"content":{"rendered":"\n

Chile has approved a user instruction for the control of serial numbers in human pharmaceutical products, reinforcing quality and safety measures through mandatory risk-based evaluations before distribution and use ****.<\/p>\n

\n
\n
CHILE – PHARMACEUTICALS<\/div>\n

Chile Mandates Risk Checks for Pharma Serial Numbers<\/h3>\n

Manufacturers must conduct risk-based evaluations before products can be distributed.<\/p>\n <\/div>\n\n

\n

What changed<\/h4>\n
\n <\/svg><\/span>\n

Mandatory risk-based evaluation<\/strong> required for each lot or sublot before distribution and use.<\/p>\n <\/div>\n

\n <\/svg><\/span>\n

Documentation review<\/strong> of manufacturing and control records is now mandatory.<\/p>\n <\/div>\n

\n <\/svg><\/span>\n

Analytical evaluations<\/strong> must be conducted for every lot, especially for biological products.<\/p>\n <\/div>\n

\n <\/svg><\/span>\n

Specific lot release rules<\/strong> apply to vaccines and blood products.<\/p>\n <\/div>\n <\/div>\n\n

\n

Who it affects<\/h4>\n
\n <\/svg><\/span>\n

Human pharmaceutical manufacturers<\/strong> must replace the previous resolution with the new serial control framework.<\/p>\n <\/div>\n

\n <\/svg><\/span>\n

Biological product producers<\/strong> must adhere to specific control subprocesses for vaccines and blood products.<\/p>\n <\/div>\n <\/div>\n\n

\n

What to do<\/h4>\n

Review manufacturing and control documentation for each lot.<\/p><\/div>\n

Conduct analytical evaluations based on risk assessment.<\/p><\/div>\n

Ensure independent checks are completed before distribution.<\/p><\/div>\n <\/div>\n\n

Chile \u2014 pharmaceutical serial control framework<\/figcaption>\n<\/figure>\n

Summary<\/h2>\n

The question addresses Chile\u2019s regulatory framework for serial number control and batch release of human pharmaceutical products<\/strong>, focusing on mandatory risk-based evaluations before distribution and use.<\/p>\n